XML 38 R31.htm IDEA: XBRL DOCUMENT v3.21.4
Note 1 - Nature of the Business and Basis of Preparation - Schedule of Subsidiaries (Details)
Sep. 30, 2021
BeyondSpring Pharmaceuticals Inc. [Member]  
Equity method investment, ownership percentage 100.00%
BeyondSpring Ltd. [Member]  
Equity method investment, ownership percentage 100.00%
BeyondSpring HK Limited [Member]  
Equity method investment, ownership percentage 100.00%
Wanchun Biotechnology Limited [Member]  
Equity method investment, ownership percentage 100.00%
Wanchun Biotechnology (Shenzhen) Ltd. [Member]  
Equity method investment, ownership percentage 100.00%
Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”) [Member]  
Equity method investment, ownership percentage 58.00%
BeyondSpring Pharmaceuticals Australia PTY Ltd. (“BeyondSpring Australia”) [Member]  
Equity method investment, ownership percentage 100.00%
Beijing Wanchun Pharmaceutical Technology Ltd. [Member]  
Equity method investment, ownership percentage 58.00%
SEED Therapeutics1 Inc. [Member]  
Equity method investment, ownership percentage 59.00%
SEED Technology Limited [Member]  
Equity method investment, ownership percentage 58.00%
SEED Therapeutics US, Inc. [Member]  
Equity method investment, ownership percentage 59.00%